Provided by Tiger Trade Technology Pte. Ltd.

Crescent Biopharma Inc

17.18
-1.6200-8.62%
Post-market: 17.180.00000.00%16:10 EDT
Volume:528.88K
Turnover:9.45M
Market Cap:638.13M
PE:-2.32
High:19.26
Open:18.87
Low:17.09
Close:18.80
52wk High:27.41
52wk Low:8.72
Shares:37.14M
Float Shares:15.95M
Volume Ratio:1.89
T/O Rate:3.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.4105
EPS(LYR):-12.8150
ROE:-160.75%
ROA:-69.15%
PB:8.80
PE(LYR):-1.34

Loading ...

Geron Appoints Chinmaya Rath as Chief Business Officer

Reuters
·
Jul 13

Eupraxia Pharma Adds Robert Bazemore, Amy Pott, Helen Thackray to Board

Reuters
·
Jul 07

Crescent Biopharma - May Offer and Sell up to $500 Mln of Securities - SEC Filing

THOMSON REUTERS
·
Jul 02

Crescent Biopharma Grants Inducement Stock Options for 65,100 Shares at $16.99 Each

Reuters
·
Jun 27

Stifel Nicolaus Reaffirms Their Buy Rating on Crescent Biopharma (CBIO)

TIPRANKS
·
Jun 23

Crescent Biopharma grants inducement stock options for 23,550 shares at $17.57 each

Reuters
·
Jun 12

Crescent Biopharma shareholders elect two Class II directors at annual meeting

Reuters
·
Jun 03

Crescent Biopharma to present at Jefferies Global Healthcare Conference fireside chat

Reuters
·
Jun 03

Crescent Biopharma Shares Fall After HC Wainwright Downgrade

MT Newswires Live
·
Jun 02

Analysts Are Bullish on These Healthcare Stocks: Crescent Biopharma (CBIO), IQVIA Holdings (IQV)

TIPRANKS
·
Jun 01

Crescent Biopharma Cut to Neutral From Buy by HC Wainwright & Co.

Dow Jones
·
Jun 01

Crescent Biopharma downgraded to Neutral from Buy at H.C. Wainwright

TIPRANKS
·
Jun 01

Crescent Biopharma grants inducement stock options for 16,950 shares at $21.47 each

Reuters
·
May 30

Analysts Offer Insights on Healthcare Companies: Roivant Sciences (ROIV), Crescent Biopharma (CBIO) and Genmab (GMAB)

TIPRANKS
·
May 26

Crescent Biopharma presents ASCEND Phase 1/2 CR-001 trial-in-progress at ASCO 2026

Reuters
·
May 22

Crescent Biopharma Announces Trial in Progress Presentation for Ascend Study of Cr-001, a Pd-1 X Vegf Bispecific Antibody, at Upcoming American Society of Clinical Oncology (Asco) 2026 Annual Meeting

THOMSON REUTERS
·
May 22

Crescent Biopharma grants inducement stock options for 129,075 shares at $18.52

Reuters
·
May 13

Rainbows and Unicorns: Crescent Biopharma, Inc. (NASDAQ:CBIO) Analysts Just Became A Lot More Optimistic

Simply Wall St.
·
May 07

Crescent Biopharma Down Over 16%, On Pace for Largest Percent Decrease Since July 2024 -- Data Talk

Dow Jones
·
May 01

Stifel Nicolaus Keeps Their Buy Rating on Crescent Biopharma (CBIO)

TIPRANKS
·
May 01